Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875 · see citing works

The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,203 · see citing works

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B. M., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6 · Cited by 1,088 · see citing works

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Lane, J. M., Marcove, R. C., Applewhite, A., Vlamis, V., & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 675 · see citing works

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6 · Cited by 582 · see citing works

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

Eilber, F. R., Giuliano, A. E., Eckardt, J. J., Patterson, K., Moseley, S. H., & Goodnight, J. E. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 524 · see citing works

Osteogenic sarcoma. A study of six hundred cases.

Dahlin, D. C., & Coventry, M. B. (1967) · PubMed · Cited by 475 · see citing works

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

Provisor, A. J., Ettinger, L. J., Nachman, J. B., Krailo, M., Makley, J. T., Yunis, E. J., Huvos, A. G., Betcher, D. L., Baum, E. S., Kisker, C. T., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.76 · Cited by 458 · see citing works

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfürst, C., Berger, J., Ritter, J., Jürgens, H., & Gerein, V. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.329 · Cited by 457 · see citing works

Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Applewhite, A., Sun, M., & LaQuaglia, M. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.449 · Cited by 389 · see citing works

Osteogenic Sarcoma under the Age of Twenty-one

Marcove, R. C., Miké, V., HAJEK, J. V., LEVIN, A. G., & Hutter, R. V. P. (1970) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197052030-00001 · Cited by 365 · see citing works

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.

Sæter, G., Alvegård, T. A., Elomaa, I., Stenwig, A. E., Holmström, T., & Solheim, Ø. P. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.10.1766 · Cited by 224 · see citing works

Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

Killander, D., Dohlwitz, A., Engstedt, L., Franzén, S., Gahrton, G., GULLBRING, B., Holm, G., Holmgren, A., Höglund, S., KILLANDER, A., et al. (1976) · Cancer · doi:10.1002/1097-0142(197601)37:1 · Cited by 143 · see citing works

Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.

Bacci, G., Mercuri, M., Briccoli, A., Ferrari, S., Bertoni, F., Donati, D. M., Monti, C., Zanoni, A., Forni, C., & Manfrini, M. (1997) · PubMed · Cited by 109 · see citing works

Prognostic Variables in Osteosarcoma: A Multi-Institutional Study

Taylor, W. F., Ivins, J. C., Unni, K. K., Beabout, J. W., Golenzer, H. J., & Black, L. E. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.1.21 · Cited by 69 · see citing works

Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy

Mena, H., García, J. H., & Velandia, F. (1981) · Cancer · doi:10.1002/1097-0142(19811015)48:8 · Cited by 37 · see citing works

Current combined treatment of high-grade osteosarcomas.

Ta, D., & Dj, P. (1995) · PubMed · Cited by 12 · see citing works

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Isakoff, M. S., Bielack, S., Meltzer, P. S., & Gorlick, R. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,578 · see citing works

Osteosarcoma treatment – Where do we stand? A state of the art review

Lütke, A., Meyers, P. A., Lewis, I. J., & Juergens, H. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,237 · see citing works

Biology and Therapeutic Advances for Pediatric Osteosarcoma

Marina, N. M., Gebhardt, M. C., Teot, L. A., & Gorlick, R. G. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-422 · Cited by 663 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456 · see citing works

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegård, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 432 · see citing works

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316 · see citing works

Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma

Gorlick, R. G., Huvos, A. G., Heller, G., Aledo, A., Beardsley, G. P., Healey, J. H., & Meyers, P. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2781 · Cited by 301 · see citing works

Metastatic osteosarcoma: a challenging multidisciplinary treatment

Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 300 · see citing works

Current Treatment of Osteosarcoma

Ferguson, W. S., & Goorin, A. M. (2001) · Cancer Investigation · doi:10.1081/cnv-100102557 · Cited by 295 · see citing works

Sarcoma

Skubitz, K. M., & D’Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 277 · see citing works

New targets and approaches in osteosarcoma

Gill, J. B., Ahluwalia, M., Geller, D., & Gorlick, R. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.003 · Cited by 274 · see citing works

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors

Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00105-5 · Cited by 260 · see citing works

Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients

Rozen, P., Lubin, F., Papo, N., Knaani, J., Farbstein, H., Farbstein, M., & Zajicek, G. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4 · Cited by 27 · see citing works

Osteosarcoma: Review of the Past, Impact on the Future. The American Experience

Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_12 · Cited by 252 · see citing works

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group

Chou, A. J., Kleinerman, E. S., Krailo, M. D., Chen, Z., Betcher, D. L., Healey, J. H., Conrad, E. U., Nieder, M. L., Weiner, M. A., Wells, R. J., et al. (2009) · Cancer · doi:10.1002/cncr.24566 · Cited by 245 · see citing works

Surgical options for children with osteosarcoma

Grimer, R. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01734-1 · Cited by 238 · see citing works

Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results

Hayashida, Y., Yakushiji, T., Awai, K., Katahira, K., Nakayama, Y., Shimomura, O., Kitajima, M., Hirai, T., Yamashita, Y., & Mizuta, H. (2006) · European Radiology · doi:10.1007/s00330-006-0342-y · Cited by 209 · see citing works

Programmed Cell Death Ligand 1 Expression in Osteosarcoma

Shen, J. K., Cote, G. M., Choy, E., Yang, P., Harmon, D. C., Schwab, J. H., Nielsen, G. P., Chebib, I. A., Ferrone, S., Wang, X., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0224 · Cited by 195 · see citing works

Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival

Petrilli, A. S., de Camargo, B., Filho, V. O., Bruniera, P., Brunetto, A. L., Jesús-García, R., de Camargo, O. P., Pena, W., Baptista, P. P. R., Davi, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5352 · Cited by 188 · see citing works

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.

Ulaner, G. A., Huang, H.-Y., Otero, J. E., Zhao, Z., Ben‐Porat, L., Satagopan, J. M., Gorlick, R. G., Meyers, P. A., Healey, J. H., Huvos, A. G., et al. (2003) · PubMed · Cited by 183 · see citing works

Improved outcomes in patients with osteogenic sarcoma of the head and neck

Patel, S. G., Meyers, P. A., Huvos, A. G., Wolden, S. L., Singh, B., Shaha, A. R., Boyle, J. O., Pfister, D. G., Shah, J. P., & Kraus, D. H. (2002) · Cancer · doi:10.1002/cncr.10849 · Cited by 179 · see citing works

Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma

Chi, S. N., Gardner, S. L., Levy, A., Knopp, E. A., Miller, D. C., Wisoff, J. H., Weiner, H. L., & Finlay, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.126 · Cited by 176 · see citing works

Neoadjuvant chemotherapy for osteosarcoma of the extremity

Bacci, G., Briccoli, A., Ferrari, S., Longhi, A., Mercuri, M., Capanna, R., Donati, D. M., Lari, S., Forni, C., & PAOLIS, M. D. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00229-5 · Cited by 173 · see citing works

SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients

Deley, M. L., Guinebretière, J. M., Gentet, J., Pacquement, H., Pichon, F., Marec‐Bérard, P., Entz‐Werlé, N., Schmitt, C., Brugières, L., Vanel, D., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.023 · Cited by 160 · see citing works

Mechanisms of methotrexate resistance in osteosarcoma.

Guo, W., Healey, J. H., Meyers, P. A., Ladanyi, M., Huvos, A. G., Bertino, J. R., & Gorlick, R. G. (1999) · PubMed · Cited by 152 · see citing works

National Cancer Data Base report on osteosarcoma of the head and neck

Smith, R. B., Apostolakis, L. W., Karnell, L. H., Koch, B. B., Robinson, R. A., Zhen, W. K., Menck, H. R., & Hoffman, H. T. (2003) · Cancer · doi:10.1002/cncr.11716 · Cited by 151 · see citing works

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review

Daw, N. C., Chou, A. J., Jaffe, N., Rao, B. N., Billups, C. A., Galindo, C. R., Meyers, P. A., & Huh, W. W. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.585 · Cited by 149 · see citing works

Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities

Machak, G. N., Si, T., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Кочергина, Н. В., Ryjkov, A. D., Тепляков, В. В., Bokhyan, B. Y., & Glebovskaya, V. V. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.147 · Cited by 149 · see citing works

Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models

Arunachalam, H. B., Mishra, R., Daescu, O., Cederberg, K., Rakheja, D., Sengupta, A. L., Leonard, D., Hallac, R. R., & Leavey, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210706 · Cited by 146 · see citing works

Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations

Suehara, Y., Alex, D., Bowman, A., Middha, S., Zehir, A., Chakravarty, D., Wang, L., Jour, G., Nafa, K., Hayashi, T., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4032 · Cited by 135 · see citing works

High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study

Fagioli, F., Aglietta, M., Tienghi, A., Ferrari, S., del Prever, A. B., Vassallo, E., Palmero, A., Biasin, E., Bacci, G., Picci, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.081 · Cited by 133 · see citing works

Treatment of osteosarcoma at first recurrence after contemporary therapy

Chou, A. J., Merola, P. R., Wexler, L. H., Gorlick, R. G., Vyas, Y. M., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., & Meyers, P. A. (2005) · Cancer · doi:10.1002/cncr.21417 · Cited by 132 · see citing works

Osteogenic and Ewing Sarcomas: Estimation of Necrotic Fraction during Induction Chemotherapy with Dynamic Contrast-enhanced MR Imaging

Dyke, J. P., Panicek, D. M., Healey, J. H., Meyers, P. A., Huvos, A. G., Schwartz, L. H., Thaler, H. T., Tofts, P. S., Gorlick, R. G., Koutcher, J. A., et al. (2003) · Radiology · doi:10.1148/radiol.2281011651 · Cited by 125 · see citing works

Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 120 · see citing works

[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

Hawkins, D. S., Conrad, E. U., Butrynski, J. E., Schuetze, S. M., & Eary, J. F. (2009) · Cancer · doi:10.1002/cncr.24421 · Cited by 119 · see citing works

Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma

Guo, J., Reddick, W. E., Glass, J. O., Ji, Q., Billups, C. A., Wu, J., Hoffer, F. A., Kaste, S. C., Jenkins, J. J., Flores, X. C. O., et al. (2011) · Cancer · doi:10.1002/cncr.26701 · Cited by 113 · see citing works

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Kubo, T., Piperdi, S., Rosenblum, J., Antonescu, C. R., Chen, W., Kim, H., Huvos, A. G., Sowers, R. S., Meyers, P. A., Healey, J. H., et al. (2008) · Cancer · doi:10.1002/cncr.23437 · Cited by 112 · see citing works

Lumbar Spine MRI for Low Back Pain: Indications and Yield

Roudsari, B. S., & Jarvik, J. G. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4367 · Cited by 112 · see citing works

Telomerase Expression Predicts Unfavorable Outcome in Osteosarcoma

Sanders, R. P., Drissi, R., Billups, C. A., Daw, N. C., Valentine, M. B., & Dome, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.043 · Cited by 108 · see citing works

Emerging roles for long noncoding RNAs in skeletal biology and disease

Huynh, N. P. T., Anderson, B. A., Guilak, F., & McAlinden, A. (2016) · Connective Tissue Research · doi:10.1080/03008207.2016.1194406 · Cited by 104 · see citing works

International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience

Marina, N. M., Bielack, S., Whelan, J. S., Smeland, S., Krailo, M., Sydes, M. R., Butterfaß‐Bahloul, T., Calaminus, G., & Bernstein, M. L. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_18 · Cited by 102 · see citing works

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

Peiffert, D., Giovannini, M. F., Ducreux, M. P., Michel, P., François, É., Lemanski, C., Mirabel, X., Cvitkovic, F., Luporsi, É., Conroy, T., et al. (2001) · Annals of Oncology · doi:10.1023/a:1011107105538 · Cited by 99 · see citing works

Dietary Nitrate Supplementation Protects Against Doxorubicin-Induced Cardiomyopathy by Improving Mitochondrial Function

Zhu, S.-G., Kukreja, R. C., Das, A., Chen, Q., Lesnefsky, E. J., & Xi, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.024 · Cited by 96 · see citing works

Staging of Primary Malignancies of Bone

Heck, R. K., Peabody, T. D., & Simon, M. A. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.366 · Cited by 96 · see citing works

Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production

Huang, C. C., Hsu, P. C., Hung, Y.-C., Liao, Y. F., Liu, C. C., Hour, C. T., Kao, M.-C., Tsay, G. J., Hung, H., & Liu, G. Y. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2947-z · Cited by 88 · see citing works

Outcome after local recurrence of osteosarcoma

Galindo, C. R., Shah, N. N., McCarville, M. B., Billups, C. A., Neel, M. N., Rao, B. N., & Daw, N. C. (2004) · Cancer · doi:10.1002/cncr.20214 · Cited by 84 · see citing works

Management of osteosarcoma

Whelan, J. S., Seddon, B. M., & Perisoglou, M. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0020-y · Cited by 84 · see citing works

Quality of Life Following Amputation or Limb Preservation in Patients with Lower Extremity Bone Sarcoma

Mason, G. E., Aung, L., Gall, S., Meyers, P. A., Butler, R., Krüg, S., Kim, M., Healey, J. H., & Gorlick, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00210 · Cited by 81 · see citing works

Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials

Eselgrim, M., Grunert, H., Kühne, T., Zoubek, A., Kevric, M., Buerger, H., Jürgens, H., Mayer‐Steinacker, R., Gosheger, G., & Bielack, S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20608 · Cited by 80 · see citing works

Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma

Meyers, P. A., & Chou, A. J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_17 · Cited by 79 · see citing works

Nonmetastatic Osteosarcoma of the Extremity: Results of a Neoadjuvant Chemotherapy Protocol (IOR/OS-3) with High-dose Methotrexate, Intraarterial or Intravenous Cisplatin, Doxorubicin, and Salvage Chemotherapy Based on Histologic Tumor Response

Ferrari, S., Mercuri, M., Picci, P., Bertoni, F., del Prever, A. B., Tienghi, A., Mancini, A. F., Longhi, A., Rimondini, S., Donati, D. M., et al. (1999) · Tumori Journal · doi:10.1177/030089169908500607 · Cited by 79 · see citing works

Magnetic resonance imaging of bone marrow in oncology, Part 2

Hwang, S., & Panicek, D. M. (2007) · Skeletal Radiology · doi:10.1007/s00256-007-0308-4 · Cited by 78 · see citing works

Early Equivalence of Uncemented Press-fit and Compress® Femoral Fixation

Farfalli, G. L., Boland, P. J., Morris, C. D., Athanasian, E. A., & Healey, J. H. (2009) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-009-0912-9 · Cited by 76 · see citing works

Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic

Igarashi, K., Kawaguchi, K., Kiyuna, T., Miyake, K., Miyake, M., Li, S., Han, Q., Tan, Y., Zhao, M. D., Li, Y., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1431596 · Cited by 75 · see citing works

High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance

Jaffe, N., & Gorlick, R. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7793 · Cited by 74 · see citing works

Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial

Ferguson, W. S., Harris, M. B., Goorin, A. M., Gebhardt, M. C., Link, M. P., Shochat, S. J., Siegal, G. P., Devidas, M., & Grier, H. E. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200108000-00004 · Cited by 72 · see citing works

Neoadjuvant Chemotherapy for Osteosarcoma of the Extremity

Bacci, G., Forni, C., Ferrari, S., Longhi, A., Bertoni, F., Mercuri, M., Donati, D. M., Capanna, R., Bernini, G., Briccoli, A., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200311000-00006 · Cited by 70 · see citing works

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas

Palmerini, E., Colangeli, M., Nanni, C., Fanti, S., Marchesi, E., Paioli, A., Picci, P., Cambioli, S., Donati, D. M., Cevolani, L., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3509-z · Cited by 69 · see citing works

The Current and Future Therapies for Human Osteosarcoma

Lamplot, J. D., Denduluri, S. K., Qin, J., Li, R., Liu, X., Zhang, H., Chen, X., Wang, N., Pratt, A., Shui, W., et al. (2013) · Current Cancer Therapy Reviews · doi:10.2174/1573394711309010006 · Cited by 67 · see citing works

Human osteosarcoma expresses specific ephrin profiles

Varelias, A., Koblar, S. A., Cowled, P. A., Carter, C. D., & Clayer, M. (2002) · Cancer · doi:10.1002/cncr.10749 · Cited by 67 · see citing works

Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung

Chou, A. J., Gupta, R., Bell, M. D., O’Day, K., Meyers, P. A., & Gorlick, R. G. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24438 · Cited by 66 · see citing works

The Folate Receptor α Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate

Yang, R. R., Kolb, E. A., Qin, J., Chou, A. J., Sowers, R. S., Hoang, B. H., Healey, J. H., Huvos, A. G., Meyers, P. A., & Gorlick, R. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1343 · Cited by 64 · see citing works

Chemotherapy for Bone Sarcoma in Adults

Wagner, M. J., Livingston, J. A., PATEL, S. R., & Benjamin, R. S. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.009944 · Cited by 62 · see citing works

Chemotherapy in head and neck osteosarcoma: Adjuvant chemotherapy improves overall survival

Chen, Y., Gokavarapu, S., Shen, Q., Liu, F., Cao, W., Ling, Y.-H., & Ji, T. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.08.017 · Cited by 62 · see citing works

The patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience

Chi, S. N., Conklin, L. S., Qin, J., Meyers, P. A., Huvos, A. G., Healey, J. H., & Gorlick, R. G. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10420 · Cited by 63 · see citing works

Diffusion-Weighted MR Imaging in Musculoskeletal Radiology: Applications in Trauma, Tumors, and Inflammation

Bley, T. A., Wieben, O. E., & Uhl, M. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.01.005 · Cited by 64 · see citing works

Results of Treatment for Metastatic Osteosarcoma With Neoadjuvant Chemotherapy and Surgery

Thompson, R. C., Cheng, E. Y., Clohisy, D. R., Perentesis, J. P., Manivel, C. J., & Le, C. T. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00028 · Cited by 62 · see citing works

Historical Perspective on the Introduction and Use of Chemotherapy for the Treatment of Osteosarcoma

Jaffe, N. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_1 · Cited by 61 · see citing works

Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma

Meyers, P. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0_11 · Cited by 61 · see citing works

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high‐risk osteosarcoma patients

Berger, M., Grignani, G., Ferrari, S., Biasin, E., Adalberto, B. D. P., Sandra, A., Saglio, F., Aglietta, M., & Franca, F. (2009) · Cancer · doi:10.1002/cncr.24368 · Cited by 61 · see citing works

Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy

Duffaud, F., Digue, L., Mercier, C., Dalès, J.-P., Baciuchka-Palmaro, M., Volot, F. G., Thomas, P. A., & Favre, R. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00435-0 · Cited by 58 · see citing works

Histologic Response of High-Grade Nonmetastatic Osteosarcoma of the Extremity to Chemotherapy

Bacci, G., Ferrari, S. M., Bertoni, F., Picci, P., Bacchini, P., Longhi, A., Donati, D. M., Forni, C., Campanacci, L., & Campanacci, M. (2001) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200105000-00024 · Cited by 57 · see citing works

Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

Yang, R. R., Sowers, R. S., Mazza, B., Healey, J. H., Huvos, A. G., Grier, H. E., Bernstein, M. L., Beardsley, G. P., Krailo, M., Devidas, M., et al. (2003) · PubMed · Cited by 57 · see citing works

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

Spraker‐Perlman, H. L., Barkauskas, D. A., Krailo, M., Meyers, P. A., Schwartz, C. L., Doski, J. J., Gorlick, R. G., Janeway, K. A., & Isakoff, M. S. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27444 · Cited by 56 · see citing works

Adjuvant therapy of osteosarcoma—A Phase II trial

Zalupski, M. M., Rankin, C. J., Ryan, J. R., Lucas, D. R., Muler, J. H., Lanier, K. S., Budd, G. T., Biermann, J. S., Meyers, F. J., & Antman, K. H. (2004) · Cancer · doi:10.1002/cncr.20021 · Cited by 56 · see citing works

Over‐expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma

Yang, R., Hoang, B. H., Kubo, T., Kawano, H., Chou, A. J., Sowers, R. S., Huvos, A. G., Meyers, P. A., Healey, J. H., & Gorlick, R. G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22749 · Cited by 55 · see citing works

Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience

Vásquez, L., Tarrillo, F., Oscanoa, M., Maza, I., Gerónimo, J., Paredes, G., Silva, J. M., & Sialer, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00022 · Cited by 55 · see citing works

Treatment of Metastatic Osteosarcoma With the Somatostatin Analog OncoLar: Significant Reduction of Insulin-Like Growth Factor-1 Serum Levels

Mansky, P. J., Liewehr, D. J., Steinberg, S. M., Chrousos, G. P., Avila, N. A., Long, L., Bernstein, D. B., Mackall, C. L., Hawkins, D. S., & Helman, L. J. (2002) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200208000-00007 · Cited by 55 · see citing works

Osteosarcoma in Pediatric Patients and Young Adults: A Single Institution Retrospective Review of Presentation, Therapy, and Outcome

Haddox, C. L., Han, G., Anijar, L., Binitie, O. T., Letson, G. D., Bui, M. M., & Reed, D. R. (2014) · Sarcoma · doi:10.1155/2014/402509 · Cited by 53 · see citing works

A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology

Igarashi, K., Murakami, T., Kawaguchi, K., Kiyuna, T., Miyake, K., Zhang, Y., Nelson, S. D., Dry, S., Li, Y., Yanagawa, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19095 · Cited by 54 · see citing works

Treatment algorithm for locally recurrent osteosarcoma based on local disease‐free interval and the presence of lung metastasis

Nathan, S. S., Gorlick, R. G., Bukata, S. V., Chou, A. J., Morris, C. D., Boland, P. J., Huvos, A. G., Meyers, P. A., & Healey, J. H. (2006) · Cancer · doi:10.1002/cncr.22197 · Cited by 54 · see citing works

Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?

Yamamoto, N., & Tsuchiya, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.827171 · Cited by 54 · see citing works

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

Sowers, R. S., Toguchida, J., Qin, J., Meyers, P. A., Healey, J. H., Huvos, A. G., Banerjee, D., Bertino, J. R., & Gorlick, R. G. (2003) · PubMed · Cited by 53 · see citing works

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

Bishop, M. W., Chang, Y., Krailo, M. D., Meyers, P. A., Provisor, A. J., Schwartz, C. L., Marina, N. M., Teot, L. A., Gebhardt, M. C., Gorlick, R., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26034 · Cited by 52 · see citing works

Prognostic significance of immunohistochemical expression of ezrin in non‐metastatic high‐grade osteosarcoma

Ferrari, S., Zanella, L., Alberghini, M., Palmerini, E., Staals, E. L., & Bacchini, P. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21360 · Cited by 52 · see citing works

The Synergistic Anticancer Effect of Artesunate Combined with Allicin in Osteosarcoma Cell Line in Vitro and in Vivo

Jiang, W., Huang, Y., Wang, J.-P., Yu, X., & Lin-yi, Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.8.4615 · Cited by 52 · see citing works

Reduced folate carrier protein expression in osteosarcoma

Ifergan, I., Meller, I., Isakov, J., & Assaraf, Y. G. (2003) · Cancer · doi:10.1002/cncr.11741 · Cited by 51 · see citing works

Evolving gene therapy approaches for osteosarcoma using viral vectors: review.

Witlox, M., Lamfers, M., Wuisman, P., Curiel, D. T., & Siegal, G. P. (2007) · Bone · doi:10.1016/j.bone.2006.10.017 · Cited by 59 · see citing works

18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma

Davis, J. C., Daw, N. C., Navid, F., Billups, C. A., Wu, J., Bahrami, A., Jenkins, J. J., Snyder, S. E., Reddick, W. E., Santana, V. M., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190595 · Cited by 50 · see citing works

The role of caspases in methotrexate-induced gastrointestinal toxicity

Papaconstantinou, H. T., Xie, C., Zhang, W., Ansari, N. H., Hellmich, M. R., Townsend, C. M., & Ko, T. C. (2001) · Surgery · doi:10.1067/msy.2001.117376 · Cited by 49 · see citing works

Delaying surgery with chemotherapy for osteosarcoma of the extremities

Bielack, S., Machatschek, J.-N., Flege, S., & Jürgens, H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1243 · Cited by 49 · see citing works

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

Kudawara, I., Aoki, Y., Ueda, T., Araki, N., Naka, N., Nakanishi, H., Matsumine, A., Ieguchi, M., Mori, S., Myoui, A., et al. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000055 · Cited by 48 · see citing works

A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma

Voûte, P. A., Souhami, R. L., Nooij, M. A., Somers, R., Cortés-Funes, H., van der Eijken, J. W., Pringle, J. A. S., Hogendoorn, P. C. W., Kirkpatrick, A., Uscinska, B., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008361612767 · Cited by 48 · see citing works

Biomarkers in osteosarcoma

Kong, C., & Hansen, M. F. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050802608496 · Cited by 47 · see citing works

Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications

Xi, L., Zhu, S., Das, A., Chen, Q., Durrant, D., Hobbs, D. C., Lesnefsky, E. J., & Kukreja, R. C. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.006 · Cited by 47 · see citing works

Methotrexate for high-grade osteosarcoma in children and young adults

van Dalen, E. C., van As, J. W., & de Camargo, B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006325.pub3 · Cited by 47 · see citing works

Metachronous Skeletal Osteosarcoma in Patients Treated with Adjuvant and Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma

Aung, L., Gorlick, R. G., Healey, J. H., Shi, W., Thaler, H. T., Shorter, N. A., Huvos, A. G., & Meyers, P. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.177 · Cited by 47 · see citing works

Outcome of surgical treatment of pelvic osteosarcoma

Guo, W., Sun, X., Ji, T., & Tang, X. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23076 · Cited by 46 · see citing works

Osteosarcoma of head and neck: A retrospective study on prognostic factors from a single institute database

Chen, Y., Shen, Q., Gokavarapu, S., Lin, C., Yahiya, Cao, W., Chauhan, S., Liu, Z., Ji, T., & Tian, Z. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.04.008 · Cited by 46 · see citing works

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Lane, J. M., Marcove, R. C., Applewhite, A., Vlamis, V., & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 675 · see citing works

Neoadjuvant Chemotherapy for Osteosarcoma of the Extremity

Bacci, G., Forni, C., Ferrari, S., Longhi, A., Bertoni, F., Mercuri, M., Donati, D. M., Capanna, R., Bernini, G., Briccoli, A., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200311000-00006 · Cited by 70 · see citing works

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.

Sæter, G., Alvegård, T. A., Elomaa, I., Stenwig, A. E., Holmström, T., & Solheim, Ø. P. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.10.1766 · Cited by 224 · see citing works

Preoperative (Neoadjuvant) Chemotherapy for Osteogenic Sarcoma: A Ten Year Experience

Rosen, G. (1985) · Orthopedics · doi:10.3928/0147-7447-19850501-19 · Cited by 145 · see citing works

Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12).

Rosen, G., & Nirenberg, A. (1985) · PubMed · Cited by 37 · see citing works